Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Temple

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Journal of Biopharmaceutical Statistics|March 19, 2004
Assessing tumor-related signs and symptoms to support cancer drug approvalGrant Williams, Richard Pazdur, Robert Temple
Archives of Internal Medicine|November 16, 2011
Balancing transparency and uncertaintyGerald J Dal Pan, Robert Temple
Pharmacoepidemiology and Drug Safety|July 5, 2012
Removal from labeling of 60-mg citalopram doseRobert Temple, Thomas Laughren, Norman Stockbridge
American Journal of Medical Genetics. Part A|August 18, 2017
Challenges of developing and conducting clinical trials in rare disordersLucas Kempf, Jonathan C Goldsmith, Robert Temple
Journal of Clinical Pharmacy and Therapeutics|September 20, 2021
U.S. racial and ethnic participation in global clinical trials by therapeutic areasMilena Lolic, Richardae Araojo, Melvyn Okeke, et al.
Reviews in Endocrine & Metabolic Disorders|March 3, 2010
Impact of cardiovascular outcomes on the development and approval of medications for the treatment of diabetes mellitusHylton V Joffe, Mary H Parks, Robert Temple
The New England Journal of Medicine|August 9, 2013
Zolpidem and driving impairment--identifying persons at riskRonald H Farkas, Ellis F Unger, Robert Temple
The New England Journal of Medicine|April 15, 2011
Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatranB Nhi Beasley, Ellis F Unger, Robert Temple
The New England Journal of Medicine|July 28, 2021
An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's DiseaseBilly Dunn, Peter Stein, Robert Temple, et al.
Regional Anesthesia and Pain Medicine|July 4, 2009
Prevalence and risk factors predisposing to coagulopathy in patients receiving epidural analgesia for hepatic surgeryRobert Shontz, Venkateswara Karuparthy, Robert Temple, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Journal of Biopharmaceutical Statistics|March 19, 2004
Assessing tumor-related signs and symptoms to support cancer drug approvalGrant Williams, Richard Pazdur, Robert Temple
Archives of Internal Medicine|November 16, 2011
Balancing transparency and uncertaintyGerald J Dal Pan, Robert Temple
Pharmacoepidemiology and Drug Safety|July 5, 2012
Removal from labeling of 60-mg citalopram doseRobert Temple, Thomas Laughren, Norman Stockbridge
American Journal of Medical Genetics. Part A|August 18, 2017
Challenges of developing and conducting clinical trials in rare disordersLucas Kempf, Jonathan C Goldsmith, Robert Temple
Journal of Clinical Pharmacy and Therapeutics|September 20, 2021
U.S. racial and ethnic participation in global clinical trials by therapeutic areasMilena Lolic, Richardae Araojo, Melvyn Okeke, et al.
Reviews in Endocrine & Metabolic Disorders|March 3, 2010
Impact of cardiovascular outcomes on the development and approval of medications for the treatment of diabetes mellitusHylton V Joffe, Mary H Parks, Robert Temple
The New England Journal of Medicine|August 9, 2013
Zolpidem and driving impairment--identifying persons at riskRonald H Farkas, Ellis F Unger, Robert Temple
The New England Journal of Medicine|April 15, 2011
Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatranB Nhi Beasley, Ellis F Unger, Robert Temple
The New England Journal of Medicine|July 28, 2021
An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's DiseaseBilly Dunn, Peter Stein, Robert Temple, et al.
Regional Anesthesia and Pain Medicine|July 4, 2009
Prevalence and risk factors predisposing to coagulopathy in patients receiving epidural analgesia for hepatic surgeryRobert Shontz, Venkateswara Karuparthy, Robert Temple, et al.
Pageof 9